BioSpace News Archive

Sekisui Diagnostics announces the Acucy Influenza A&B Test has received 510(k) clearance as a Class II assay from the US Food and Drug Administration (FDA), as well as, CLIA Waiver (Clinical Laboratory Improvement Amendments) for use on the Acucy Reader.

Intarcia Therapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s resubmission of its new drug application (NDA) for ITCA 650 (exenatide implant), for the treatment of type 2 diabetes mellitus.

Montana Molecular announced today that the company has received two new awards from the National Institutes of Health (NIH)

Additional results from the Phase 3 confirmatory clinical trial (OPTIC) of teprotumumab, an investigational medicine being developed by Horizon Therapeutics plc, will be presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) 50th Anniversary 2019 Fall Scientific Symposium in San Francisco on Oct. 11.

Varian (NYSE: VAR) will showcase the company’s interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla.

Commercially insured Americans with Multiple Sclerosis are three times more likely to have behavioral health conditions, including major depression and substance use disorder, than the overall population, according to a new Blue Cross Blue Shield Association report.

Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, is pleased to announce that it has received its first order for OxC-beta™ Livestock in Taiwan, specifically for the use in poultry and sow feeds.

Merck KGaA, Darmstadt, Germany Designates Undisclosed Bispecific ADC as Clinical Development Candidate

$0 Copay for Generic Drugs at Home Delivery (Up to 90-Day Supply) Through the Express Scripts Saver, Value and Choice Plans

Cardiovascular Systems, Inc. will host a live webcast of its fiscal 2020 first-quarter conference call on Tuesday, October 29, 2019, at 3:30 p.m. CT (4:30 p.m. ET).